The majority of individual amino acids increase insulin and attenuate the plasma glucose response when ingested with glucose. Objective. To determine whether ingestion of two amino acids simultaneously, with glucose, would result in an additive effect. Leucine (Leu) and glycine (Gly) were chosen because they were two of the most potent glucose-lowering amino acids when given individually. Materials and Methods. Nine subjects received test items on four separate days. The first was a water control, then 25?g glucose, or Leu + Gly (1?mmol/kg fat-free mass each) ±25?g glucose, in random order. Glucose, insulin, and glucagon were measured frequently for 2.5 hours. Net areas were calculated. Results. The glucose area response decreased by 66%. The insulin area response increased by 24% after ingestion of Leu + Gly + glucose compared to ingestion of glucose alone. The decrease in glucose response was not additive; the increase in insulin response was far less than additive when compared to previously published individual amino acid results. The glucagon concentration remained unchanged. Conclusion. There is an interaction between Leu and Gly that results in a markedly attenuated glucose response. This occurred with a very modest increase in insulin response. Changes in glucagon response could not explain the results. The mechanism is unknown. 1. Introduction In a series of studies our laboratory has demonstrated that single amino acids when ingested at 1.0?mmol/kg fat free mass with or without 25?g of glucose stimulate a rise in insulin and glucagon. When ingested with glucose they are capable of attenuating the glucose rise integrated over a 2.5-hour period of time. Sixteen amino acids were studied. The potency of the individual amino acids in regard to their effect on the insulin, glucagon, and glucose concentrations varied greatly between amino acids and the specific responses could not be predicted based on the structure of the amino acids [1]. Leucine is well recognized to strongly stimulate insulin secretion and to reduce the glucose rise when ingested with glucose [2]. When ingested with glucose, glycine similarly reduced the glucose rise, but only weakly stimulated insulin secretion. [2, 3]. Therefore, we were interested in determining if the glucose-attenuating effect would be greater if these two amino acids were ingested together with glucose. We were particularly interested in whether the effects would be additive since glycine produced a major decrease in glucose response in the presence of only a very modest increase in insulin; that is, it may
References
[1]
M. C. Gannon and F. Q. Nuttall, “Amino acid ingestion and glucose metabolism—a review,” IUBMB Life, vol. 62, no. 9, pp. 660–668, 2010.
[2]
D. Kalogeropoulou, L. LaFave, K. Schweim, M. C. Gannon, and F. Q. Nuttall, “Leucine, when ingested with glucose, synergistically stimulates insulin secretion and lowers blood glucose,” Metabolism: Clinical and Experimental, vol. 57, no. 12, pp. 1747–1752, 2008.
[3]
M. C. Gannon, J. A. Nuttall, and F. Q. Nuttall, “The metabolic response to ingested glycine,” The American Journal of Clinical Nutrition, vol. 76, no. 6, pp. 1302–1307, 2002.
[4]
S. S. Fajans, J. C. Floyd Jr., R. F. Knopf, and F. W. Conn, “Effect of amino acids and proteins on insulin secretion in man.,” Recent Progress in Hormone Research, vol. 23, pp. 617–662, 1967.
[5]
A. Sener and W. J. Malaisse, “L-Leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase,” Nature, vol. 288, no. 5787, pp. 187–189, 1980.
[6]
L. A. Fahien, M. J. MacDonald, E. H. Kmiotek, R. J. Mertz, and C. M. Fahien, “Regulation of insulin release by factors that also modify glutamate dehydrogenase,” Journal of Biological Chemistry, vol. 263, no. 27, pp. 13610–13614, 1988.
[7]
C. A. Stanley, Y. K. Lieu, B. Y. L. Hsu et al., “Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene,” The New England Journal of Medicine, vol. 338, no. 19, pp. 1352–1357, 1998.
[8]
M. J. MacDonald, L. A. Fahien, L. J. Brown, N. M. Hasan, J. D. Buss, and M. A. Kendrick, “Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 288, no. 1, pp. E1–E15, 2005.
[9]
Y. Zhou, T. L. Jetton, S. Goshorn, C. J. Lynch, and P. She, “Transamination is required for α-ketoisocaproate but not leucine to stimulate insulin secretion,” Journal of Biological Chemistry, vol. 285, no. 44, pp. 33718–33726, 2010.
[10]
L. A. Fahien and M. J. MacDonald, “The complex mechanism of glutamate dehydrogenase in insulin secretion,” Diabetes, vol. 60, no. 10, pp. 2450–2454, 2011.
[11]
M. González-Ortiz, R. Medina-Santillán, E. Martínez-Abundis, and C. Reynoso von Drateln, “Effect of glycine on insulin secretion and action in healthy first-degree relatives of type 2 diabetes mellitus patients,” Hormone and Metabolic Research, vol. 33, no. 6, pp. 358–360, 2001.
[12]
K. Kasai, M. Kobayashi, and S.-I. Shimoda, “Stimulatory effect of glycine on human growth hormone secretion,” Metabolism: Clinical and Experimental, vol. 27, no. 2, pp. 201–208, 1978.
[13]
R. Medina, F. Chavez, C. Herrera et al., “Effect of glycine on plasma levels of glucose and insulin in healthy volunteers,” Proceedings of the Western Pharmacology Society, vol. 43, pp. 67–68, 2000.
[14]
W. A. Mueller, T. T. Aoki, and G. F. Cahill Jr., “Effect of alanine and glycine on glucagon secretion in postabsorptive and fasting obese man,” Journal of Clinical Endocrinology and Metabolism, vol. 40, no. 3, pp. 418–425, 1975.
[15]
A. Gameiro, F. Reimann, A. M. Habib et al., “The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line,” The Journal of Physiology, vol. 569, part 3, pp. 761–772, 2005.
[16]
M. C. Gannon, F. Q. Nuttall, B. J. Neil, and S. A. Westphal, “The insulin and glucose responses to meals of glucose plus various proteins in type II diabetic subjects,” Metabolism: Clinical and Experimental, vol. 37, no. 11, pp. 1081–1088, 1988.